These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11417034)

  • 21. Economic access to effective drugs for falciparum malaria.
    Panosian CB
    Clin Infect Dis; 2005 Mar; 40(5):713-7. PubMed ID: 15714418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Chemosensitivity of Plasmodium falciparum in Sainte Marie island, east coast of Madagascar: in vivo and in vitro studies].
    Raharimalala AL; Randrianarivelojosia M; Randriamanantena A; Ranarivelo LA; Jaureguiberry S; Rason MA; Rakotomalala E; Ariey F
    Arch Inst Pasteur Madagascar; 2000; 66(1-2):26-31. PubMed ID: 12463030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of therapeutic efficacy of chloroquine and sulphadoxine-pyrimethamine in uncomplicated falciparum malaria.
    Biswas S; Valecha N; Tyagi PK; Phookan S; Dev V; Sharma SK; Subbarao SK
    J Vector Borne Dis; 2003; 40(3-4):92-9. PubMed ID: 15119078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should chloroquine be laid to rest?
    Ginsburg H
    Acta Trop; 2005 Oct; 96(1):16-23. PubMed ID: 16054105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
    Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
    Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Efficacy of chloroquine in treatment of non-complicated malaria with Plasmodium falciparum in children at the San Pedro dispensary in Côte d'Ivoire].
    Kassi RR; Yavo W; Mokak DG; Menan HI; Barro-Kiki CP; Bamba A; Pénali KL; Koné M
    Bull Soc Pathol Exot; 2004 May; 97(2):129-30. PubMed ID: 15255359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revising antimalarial drug policy in Central America: experience in Panama.
    Calzada JE; Samudio F; Bayard V; Obaldia N; de Mosca IB; Pascale JM
    Trans R Soc Trop Med Hyg; 2008 Jul; 102(7):694-8. PubMed ID: 18436272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of pre-packaged chloroquine for the home management of presumed malaria in Malagasy children.
    Ratsimbasoa A; Randrianarivelojosia M; Millet P; Soarès JL; Rabarijaona L; Rakotoson B; Malvy D; Ménard D
    Malar J; 2006 Sep; 5():79. PubMed ID: 16972985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Current antimalarial drugs: resistance and new strategies].
    Ringwald P
    Bull Acad Natl Med; 2007 Oct; 191(7):1273-84; discussion 1284. PubMed ID: 18447049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the therapeutic efficacy of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria in a tribal block of the Kalahandi district of Orissa, India.
    Kerketta AS; Mohapatra SS; Kar SK
    Trop Doct; 2008 Apr; 38(2):82-4. PubMed ID: 18453492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Self-medication with chloroquine in a rural district of Tanzania: a therapeutic challenge for any future malaria treatment policy change in the country.
    Nsimba SE; Rimoy GH
    J Clin Pharm Ther; 2005 Dec; 30(6):515-9. PubMed ID: 16336283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug company to offer new malaria drug cheaply in Africa.
    Pincock S
    BMJ; 2003 Aug; 327(7411):360. PubMed ID: 12919982
    [No Abstract]   [Full Text] [Related]  

  • 33. Improving adherence to malaria treatment for children: the use of pre-packed chloroquine tablets vs. chloroquine syrup.
    Ansah EK; Gyapong JO; Agyepong IA; Evans DB
    Trop Med Int Health; 2001 Jul; 6(7):496-504. PubMed ID: 11469941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malaria researchers say global fund is buying "useless drug".
    Yamey G
    BMJ; 2003 Nov; 327(7425):1188. PubMed ID: 14630748
    [No Abstract]   [Full Text] [Related]  

  • 35. Malaria-treatment policies: when and how should they be changed?
    Fèvre EM; Barnish G
    Ann Trop Med Parasitol; 1999 Sep; 93(6):549-60. PubMed ID: 10707100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of health care financing reforms on the management of malaria in Ghana.
    Biritwum RB
    East Afr Med J; 2001 Dec; 78(12):636-40. PubMed ID: 12199444
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Household cost of seeking malaria care. A retrospective study of two districts in Ghana.
    Asenso-Okyere WK; Dzator JA
    Soc Sci Med; 1997 Sep; 45(5):659-67. PubMed ID: 9226789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. WHO, the Global Fund, and medical malpractice in malaria treatment.
    White N; Nosten F; Björkman A; Marsh K; Snow RW
    Lancet; 2004 Apr; 363(9415):1160. PubMed ID: 15064038
    [No Abstract]   [Full Text] [Related]  

  • 39. Malaria and money.
    Lell B
    Wien Klin Wochenschr; 2004 May; 116(9-10):286-8. PubMed ID: 15237652
    [No Abstract]   [Full Text] [Related]  

  • 40. Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals.
    Aina BA; Tayo F; Taylor O
    J Infect Dev Ctries; 2008 Feb; 2(1):68-72. PubMed ID: 19736391
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.